Evidence map›Paper›PMID 32641515›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2020

Ultrahigh-throughput magnetic sorting of large blood volumes for epitope-agnostic isolation of circulating tumor cells.

Avanish Mishra, Taronish D Dubash, Jon F Edd, Michelle K Jewett, Suhaas G Garre, Nezihi Murat Karabacak, Daniel C Rabe, Baris R Mutlu, John R Walsh, Ravi Kapur and 4 more

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 80 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
80citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

80 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Dynamic monitoring of antibody drug conjugates targeting TROP2 or HER2 in breast cancer using circulating tumor cells.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Isolation Techniques of Micro/Nano-Scaled Species for Biomedical Applications.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  20. Review

20 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Avanish MishraBioMEMS Resource Center, Charlestown, MA 02129.
Taronish D DubashCancer Center, Massachusetts General Hospital, Boston, MA 02114.
Jon F EddBioMEMS Resource Center, Charlestown, MA 02129.
Michelle K JewettBioMEMS Resource Center, Charlestown, MA 02129.
Suhaas G GarreBioMEMS Resource Center, Charlestown, MA 02129.
Nezihi Murat KarabacakBioMEMS Resource Center, Charlestown, MA 02129.ORCID 0000-0003-2761-5593
Daniel C RabeBioMEMS Resource Center, Charlestown, MA 02129.ORCID 0000-0001-6126-2280
Baris R MutluBioMEMS Resource Center, Charlestown, MA 02129.ORCID 0000-0002-1613-2804
John R WalshBioMEMS Resource Center, Charlestown, MA 02129.ORCID 0000-0002-8461-1161
Ravi KapurMicroMedicine, Inc., Waltham, MA 02451.
Shannon L StottBioMEMS Resource Center, Charlestown, MA 02129.
Shyamala MaheswaranCancer Center, Massachusetts General Hospital, Boston, MA 02114.
Daniel A HaberCancer Center, Massachusetts General Hospital, Boston, MA 02114; dhaber@mgh.harvard.edu mtoner@hms.harvard.edu.
Mehmet TonerBioMEMS Resource Center, Charlestown, MA 02129; dhaber@mgh.harvard.edu mtoner@hms.harvard.edu.ORCID 0000-0002-3647-3665

Funding

Point-of care Microfluidics for Early Detection of CancerU01EB012493 · NIBIB · MASSACHUSETTS GENERAL HOSPITAL · PI HABER, DANIEL A., TONER, MEHMET · 2010 to 2018
$19.6M
Bio-MicroElectroMechanical Systems Resource CenterP41EB002503 · NIBIB · MASSACHUSETTS GENERAL HOSPITAL · PI TONER, MEHMET · 2004 to 2018
$17.4M
Modeling Metastasis and Acquired Drug Resistance Using Circulating Tumor CellsR01CA129933 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI Daniel A. Haber · 2008 to 2026
$7.5M
Metastasis and biophysics of clusters of circulating tumor cells in the microcirculationU01CA214297 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI HABER, DANIEL A., MAHESWARAN, SHYAMALA · 2018 to 2022
$2.9M
Benchmarking the Sensitivity and Specificity of the Herringbone Microfluidic Device for Rare Particle CaptureR01CA226871 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI NAHED, BRIAN VALA, STOTT, SHANNON L · 2018 to 2023
$2.3M
The role of extracellular vesicles in regulating response to immunotherapyF32CA236417 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI RABE, DANIEL CHRISTOPHER · 2020 to 2022
$209k
Howard Hughes Medical InstituteNCI NIH HHS F32 CA236417NCI NIH HHS R01 CA129933NCI NIH HHS R01 CA226871NCI NIH HHS U01 CA214297NIBIB NIH HHS P41 EB002503NIBIB NIH HHS U01 EB012493
6 · The paper itself

Abstract

Circulating tumor cell (CTC)-based liquid biopsies provide unique opportunities for cancer diagnostics, treatment selection, and response monitoring, but even with advanced microfluidic technologies for rare cell detection the very low number of CTCs in standard 10-mL peripheral blood samples limits their clinical utility. Clinical leukapheresis can concentrate mononuclear cells from almost the entire blood volume, but such large numbers and concentrations of cells are incompatible with current rare cell enrichment technologies. Here, we describe an ultrahigh-throughput microfluidic chip,

Indexed as

Cell Line, TumorCell SeparationHigh-Throughput Screening AssaysHumansLeukapheresisMagnetic FieldsMicrofluidicsNeoplastic Cells, Circulatingcirculating tumor cellsleukapheresisliquid biopsymagnetic sortingmicrofluidics

Identifiers

PMID32641515
PMCPMC7382214

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.